sodium citrate, anhydrous and ferrous citrate
sodium citrate, anhydrous has been researched along with ferrous citrate in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Fushimi, T; Ichimoto, K; Ishii, T; Kishita, Y; Matsunaga, A; Murayama, K; Nakajima, M; Nozawa, N; Ogawa-Tominaga, M; Ohtake, A; Okazaki, Y; Shimura, M; Tajika, M; Takahashi, K; Tanaka, T; Tsuruoka, T | 1 |
Guo, WZ; Hu, X; Ito, H; Li, XK; Liu, C; Ma, K; Nakajima, M; Que, W; Ren, K; Takahashi, K; Tanaka, T; Wang, Z; Yi, SQ | 1 |
Other Studies
2 other study(ies) available for sodium citrate, anhydrous and ferrous citrate
Article | Year |
---|---|
Effects of 5-aminolevulinic acid and sodium ferrous citrate on fibroblasts from individuals with mitochondrial diseases.
Topics: Adenosine Triphosphate; Aminolevulinic Acid; Biosynthetic Pathways; Case-Control Studies; Citric Acid; DNA Copy Number Variations; DNA, Mitochondrial; Female; Ferrous Compounds; Fibroblasts; Heme; Heme Oxygenase-1; Humans; In Vitro Techniques; Infant; Infant, Newborn; Male; Mitochondrial Diseases; Oxidative Phosphorylation; Oxygen Consumption; RNA, Messenger; Sodium Citrate; Up-Regulation | 2019 |
5-Aminolevulinic acid combined with sodium ferrous citrate (5-ALA/SFC) ameliorated liver injury in a murine acute graft-versus-host disease model by reducing inflammation responses through PGC1-α activation.
Topics: Alanine Transaminase; Aminolevulinic Acid; Animals; Aspartate Aminotransferases; Citric Acid; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Ferrous Compounds; Gene Expression Regulation; Graft vs Host Disease; Levulinic Acids; Liver; Male; Mice; Mice, Inbred C57BL; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Sodium Citrate; T-Lymphocytes; Treatment Outcome; Up-Regulation | 2021 |